Quantcast
Last updated on April 24, 2014 at 14:17 EDT

Latest Oncology Stories

2014-04-21 12:27:29

SUNNYVALE, Calif., April 21, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that data from the Phase III PCYC-1112 (RESONATE(TM)) study of single agent IMBRUVICA(TM) (ibrutinib) vs. ofatumumab, an established therapy in relapsed refractory CLL, as well as data from an Independent Efficacy Evaluation of IMBRUVICA after three years of follow-up, will be presented at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting in Chicago, Illinois May 30 - June...

2014-04-20 23:01:14

A federal jury’s decision to award billions of dollars in damages to a bladder cancer patient who took Actos could mean that others in the same situation may also have a right to seek compensation. Raleigh, NC (PRWEB) April 20, 2014 Last week, the Osaka, Japan-based company that produces the diabetes drug Actos and their American marketing partner Eli Lilly were ordered to pay more than $9 billion because Takeda allegedly concealed cancer risks associated with its Actos diabetes drug....

2014-04-19 23:00:54

Japanese research suggests a biomarker called osteopontin could help some mesothelioma patients avoid the trial-and-error approach to treatment. Raleigh, NC (PRWEB) April 19, 2014 Scientists say testing for the structural glycoprotein osteopontin in mesothelioma tissue samples could help streamline the process of selecting an effective treatment. Details on the new study have just been posted on the Cancer Monthly website and can be read by clicking here. Doctors in the Department of...

2014-04-18 23:06:18

Radion, Inc., the creator of Radion Hub® software solutions, announced today the formal release of Radion Hub® Registry. A new cloud-based patient specific data capture tool that integrates clinical research in a simplified manner into oncology workflow practices. Cupertino, CA (PRWEB) April 18, 2014 Radion, Inc. launches a cloud-based application to provide clinical investigators a tool to capture patient-specific end-point data for oncology patients. Radion Hub® Registry...

2014-04-18 23:03:34

Yossi Biderman’s team of scientists, doctors and engineers have developed a non-invasive skin cancer scanning device. (PRWEB) April 18, 2014 Skin cancer, the most common form of the disease, affects one in five Americans. The best remedy for all types of skin cancer – including melanoma – is early detection, which is usually done by in a dermatologist’s office. People worried about suspicious moles or possible melanoma, however, may have to wait months for an appointment while...

2014-04-18 23:02:14

In Wake of Morcellation Lawsuit FDA Calls For Termination of Procedures Using Laparoscopic Power Morcellation That Allegedgly Causes Leiomyosarcoma, reports Alonso Krangle LLP New York, NY (PRWEB) April 18, 2014 The U.S. Food and Drug Administration (FDA) warned Thursday against using laparoscopic power morcellation during gynecological surgeries on women because the procedure can potential cause the spread uterine cancer in the abdomen and pelvis. The FDA estimates that one in 350 women...

2014-04-18 12:30:44

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching how pain occurs in nerves in the periphery of the body. Dr Marzia Malcangio said: "We have been investigating and identifying mechanisms underlying pain generation and our findings could help chemotherapy patients who suffer pain related side effects." One potential side effect of...

2014-04-18 12:13:08

Scientists have identified the first genetic variant specifically associated with the risk of a difficult-to-diagnose cancer sub-type accounting for around 10-15 per cent of all breast cancer cases. The largest ever study of the breast cancer sub-type, called invasive lobular carcinoma, gives researchers important clues to the genetic causes of this particular kind of breast cancer, which can be missed through screening. The research, published today (Thursday) in the journal PloS...

2014-04-17 23:08:10

In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights if they are diagnosed. Raleigh, NC (PRWEB) April 17, 2014 Cancer information site Cancer Monthly is advising Actos users to be aware of the symptoms of bladder cancer after a jury in the U.S. District Court for Western Louisiana concluded...

2014-04-17 23:01:36

Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug, Viagra (sildenafil citrate), which is marketed by the US-based pharmaceutical company, Pfizer. Toledo, OH (PRWEB) April 17, 2014 Studies have suggested that sildenafil use may increase the invasiveness of melanoma cells, which may raise the possible adverse effect of melanoma. On April 7, 2014, a...